Technical Analysis for AFP - AFT Pharmaceuticals Ltd
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 2.600 | 0.00% | 0.000 |
Earnings due: May 20
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bearish Signal Line Cross | Bearish | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Volume Surge | Other | -6.14% | |
| Narrow Range Bar | Range Contraction | -6.14% | |
| Outside Day | Range Expansion | -6.14% | |
| Volume Surge | Other | -6.81% | |
| Narrow Range Bar | Range Contraction | -6.81% |
| Alert | Time |
|---|---|
| 3x Volume Pace | 8 days ago |
| 2x Volume Pace | 8 days ago |
| 1.5x Volume Pace | 8 days ago |
| Possible Inside Day | 8 days ago |
| Gapped Up (Full) | 14 days ago |
Free Daily (Stock) Chart Reading
AFT Pharmaceuticals Ltd Description
AFT Pharmaceuticals Limited is a pharmaceutical distributor and developer of pharmaceutical intellectual property. The Company's segments include New Zealand, Australia, Asia and Rest of World. The Company's products include Crystaderm, Maxigesic, Coco-scalp, Maxiclear, RestoraNail and Myconail, among others. The Company's NasoSURF Nebuliser is in pilot scale production. The Company is focused on conducting clinical for Maxigesic oral dose forms. The Company is also conducting clinical trials of Maxigesic intravenous (IV). Maxigesic PE is a cold and flu variant. Its subsidiary, AFT Pharmaceuticals (AU) Pty Ltd, is engaged in distribution of pharmaceuticals in Australia. Its subsidiary, AFT Pharmaceuticals Singapore Pte Ltd, is engaged in the registration of pharmaceuticals in Singapore. Its subsidiary, AFT Pharmaceuticals (S.E. Asia) Sdn Bhd, is engaged in the distribution of pharmaceuticals in Malaysia.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health Pharmaceutical Pharmaceuticals Flu Clinical Trial Intellectual Property Ducting Pharmaceuticals Policy Pharmaceutical Industry In China Science And Technology In The People's Republic Of China
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.9073 |
| 52 Week Low | 2.5 |
| Average Volume | 1,749 |
| 200-Day Moving Average | 3.213 |
| 50-Day Moving Average | 3.054 |
| 20-Day Moving Average | 2.803 |
| 10-Day Moving Average | 2.765 |
| Average True Range | 0.093 |
| RSI (14) | 37.89 |
| ADX | 29.89 |
| +DI | 22.784 |
| -DI | 59.049 |
| Chandelier Exit (Long, 3 ATRs) | 2.721 |
| Chandelier Exit (Short, 3 ATRs) | 2.779 |
| Upper Bollinger Bands | 3.045 |
| Lower Bollinger Band | 2.561 |
| Percent B (%b) | 0.08 |
| BandWidth | 17.270 |
| MACD Line | -0.085 |
| MACD Signal Line | -0.082 |
| MACD Histogram | -0.003 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.600 | ||||
| Resistance 3 (R3) | 2.600 | 2.600 | 2.600 | ||
| Resistance 2 (R2) | 2.600 | 2.600 | 2.600 | 2.600 | |
| Resistance 1 (R1) | 2.600 | 2.600 | 2.600 | 2.600 | 2.600 |
| Pivot Point | 2.600 | 2.600 | 2.600 | 2.600 | 2.600 |
| Support 1 (S1) | 2.600 | 2.600 | 2.600 | 2.600 | 2.600 |
| Support 2 (S2) | 2.600 | 2.600 | 2.600 | 2.600 | |
| Support 3 (S3) | 2.600 | 2.600 | 2.600 | ||
| Support 4 (S4) | 2.600 |
